Meet the company trying precision medicine for autism
Swiss biotech Stalicla hopes to bring precision medicine to autism. Experts praise efforts to identify autism subgroups, but evidence to support the company’s claims has yet to be seen.
Swiss biotech Stalicla hopes to bring precision medicine to autism. Experts praise efforts to identify autism subgroups, but evidence to support the company’s claims has yet to be seen.
Overexpressing genes involved in the pathway, which regulates protein quality, changes repetitive behaviors in the animals.
People with autism have more mutations than others do in both mitochondrial DNA and nuclear DNA that affects mitochondrial function.
Clues that problems with mitochondria contribute to autism have been accumulating for decades. In the past five years, a mutant mouse and a flurry of findings have energized the field.
No diet is likely to treat autistic people on a large scale, but diets based on a genetic profile may bring big benefits to a few.
The levels of four chemicals in the brain may distinguish autism and vary with its severity, according to a new study.
Doctors can now order a blood test that its makers say may help flag autism, but experts say the test is not appropriate for use in clinics.
A new study suggests that its results could lead to a simple test for autism, but statisticians say the test could not be used to screen for the condition in the general population.
David and Bernardo Sabatini, brothers born just a year and a half year apart, invent their way to answering big questions about autism.
Cooperative problem-solving may have kept human brains small, researchers puzzle over new European online privacy rules, and Canadian officials counter unfounded claims of a cure for autism.